Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Metastatic Basal Cell Carcinoma.

Laga AC, Schaefer IM, Sholl LM, French CA, Hanna J.

Am J Clin Pathol. 2019 Nov 4;152(6):706-717. doi: 10.1093/ajcp/aqz089.

PMID:
31355851
2.

Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Haffajee RL, French CA.

Curr Opin Psychol. 2019 Feb 4;30:65-73. doi: 10.1016/j.copsyc.2019.01.018. [Epub ahead of print] Review.

PMID:
30856591
3.

A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma.

Diolaiti D, Dela Cruz FS, Gundem G, Bouvier N, Boulad M, Zhang Y, Chou AJ, Dunkel IJ, Sanghvi R, Shah M, Geiger H, Rahman S, Felice V, Wrzeszczynski KO, Darnell RB, Antonescu CR, French CA, Papaemmanuil E, Kung AL, Shukla N.

Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6). pii: a003194. doi: 10.1101/mcs.a003194. Print 2018 Dec.

4.

Spindle Cell Nuclear in Testis Carcinoma of the Lung: A Challenging Tumor.

Pelosi G, Cannone M, Balladore E, Rahal D, Bossi P, Novellis P, Bottoni E, Toschi L, Roncalli M, French CA, Veronesi G.

J Thorac Oncol. 2019 Feb;14(2):311-313. doi: 10.1016/j.jtho.2018.11.010. Epub 2018 Nov 23. No abstract available.

PMID:
30476575
5.

NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.

French CA.

Pathol Int. 2018 Nov;68(11):583-595. doi: 10.1111/pin.12727. Epub 2018 Oct 26. Review.

PMID:
30362654
6.

"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.

Shiota H, Elya JE, Alekseyenko AA, Chou PM, Gorman SA, Barbash O, Becht K, Danga K, Kuroda MI, Nardi V, French CA.

Mol Cancer Res. 2018 Dec;16(12):1826-1833. doi: 10.1158/1541-7786.MCR-18-0474. Epub 2018 Aug 23.

PMID:
30139738
7.

Differential effects of Foxp2 disruption in distinct motor circuits.

French CA, Vinueza Veloz MF, Zhou K, Peter S, Fisher SE, Costa RM, De Zeeuw CI.

Mol Psychiatry. 2019 Mar;24(3):447-462. doi: 10.1038/s41380-018-0199-x. Epub 2018 Aug 14.

8.

CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.

Schaefer IM, Dal Cin P, Landry LM, Fletcher CDM, Hanna GJ, French CA.

Genes Chromosomes Cancer. 2018 Sep;57(9):446-451. doi: 10.1002/gcc.3. Epub 2018 Aug 14.

PMID:
29700887
9.

Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.

Mito JK, Bishop JA, Sadow PM, Stelow EB, Faquin WC, Mills SE, Krane JF, French CA, Fletcher CDM, Hornick JL, Sholl LM, Jo VY.

Am J Surg Pathol. 2018 Aug;42(8):1067-1075. doi: 10.1097/PAS.0000000000001064.

PMID:
29683816
10.

NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.

Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, Hartmann A, French CA, Fisher C.

Am J Surg Pathol. 2018 Jul;42(7):877-884. doi: 10.1097/PAS.0000000000001046. Review.

11.

Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).

Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, Nehs MA, Jo VY, Lowe A, Vivero M, Hollowell M, Qian X, Wieczorek T, French CA, Teot LA, Cibas ES, Lindeman NI, Krane JF, Barletta JA.

Endocr Pathol. 2018 Mar;29(1):68-74. doi: 10.1007/s12022-018-9515-x.

PMID:
29396809
12.

Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach.

Storck S, Kennedy AL, Marcus KJ, Teot L, Vaughn J, Gnekow AK, Märkl B, Leuschner I, DuBois SG, French CA, Frühwald MC.

Pediatr Hematol Oncol. 2017 May;34(4):231-237. doi: 10.1080/08880018.2017.1363839. Epub 2017 Oct 17.

PMID:
29040054
13.

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Brägelmann J, Dammert MA, Dietlein F, Heuckmann JM, Choidas A, Böhm S, Richters A, Basu D, Tischler V, Lorenz C, Habenberger P, Fang Z, Ortiz-Cuaran S, Leenders F, Eickhoff J, Koch U, Getlik M, Termathe M, Sallouh M, Greff Z, Varga Z, Balke-Want H, French CA, Peifer M, Reinhardt HC, Örfi L, Kéri G, Ansén S, Heukamp LC, Büttner R, Rauh D, Klebl BM, Thomas RK, Sos ML.

Cell Rep. 2017 Sep 19;20(12):2833-2845. doi: 10.1016/j.celrep.2017.08.082.

14.

Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.

Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, Dal Cin P, Ince TA, Kharchenko PV, Kuroda MI, French CA.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4184-E4192. doi: 10.1073/pnas.1702086114. Epub 2017 May 8.

15.

NUT midline carcinoma of the larynx: an international series and review of the literature.

Hellquist H, French CA, Bishop JA, Coca-Pelaz A, Propst EJ, Paiva Correia A, Ngan BY, Grant R, Cipriani NA, Vokes D, Henrique R, Pardal F, Vizcaino JR, Rinaldo A, Ferlito A.

Histopathology. 2017 May;70(6):861-868. doi: 10.1111/his.13143. Epub 2017 Feb 21. Review.

16.

The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns.

Zee BM, Dibona AB, Alekseyenko AA, French CA, Kuroda MI.

PLoS One. 2016 Oct 3;11(10):e0163820. doi: 10.1371/journal.pone.0163820. eCollection 2016.

17.

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, Hsi P, Bauer DE, Lathan CS, Rodriguez-Galindo C, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA.

Cancer. 2016 Dec 1;122(23):3632-3640. doi: 10.1002/cncr.30242. Epub 2016 Aug 10.

18.

Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.

Strickland KC, Vivero M, Jo VY, Lowe AC, Hollowell M, Qian X, Wieczorek TJ, French CA, Teot LA, Sadow PM, Alexander EK, Cibas ES, Barletta JA, Krane JF.

Thyroid. 2016 Oct;26(10):1466-1471. Epub 2016 Sep 8.

PMID:
27457786
19.

Small-Molecule Targeting of BET Proteins in Cancer.

French CA.

Adv Cancer Res. 2016;131:21-58. doi: 10.1016/bs.acr.2016.04.001. Epub 2016 May 31. Review.

PMID:
27451123
20.

Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.

Bishop JA, French CA, Ali SZ.

Cancer Cytopathol. 2016 Dec;124(12):901-908. doi: 10.1002/cncy.21761. Epub 2016 Jul 11.

21.

Foxp transcription factors suppress a non-pulmonary gene expression program to permit proper lung development.

Li S, Morley M, Lu M, Zhou S, Stewart K, French CA, Tucker HO, Fisher SE, Morrisey EE.

Dev Biol. 2016 Aug 15;416(2):338-46. doi: 10.1016/j.ydbio.2016.06.020. Epub 2016 Jun 21.

22.

Labor Epidural Analgesia and Breastfeeding: A Systematic Review.

French CA, Cong X, Chung KS.

J Hum Lact. 2016 Aug;32(3):507-20. doi: 10.1177/0890334415623779. Epub 2016 Apr 27. Review.

PMID:
27121239
23.

Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.

Stathis A, Zucca E, Bekradda M, Gomez-Roca C, Delord JP, de La Motte Rouge T, Uro-Coste E, de Braud F, Pelosi G, French CA.

Cancer Discov. 2016 May;6(5):492-500. doi: 10.1158/2159-8290.CD-15-1335. Epub 2016 Mar 14.

24.

NUT Carcinoma of the Sublingual Gland.

Andreasen S, French CA, Josiassen M, Hahn CH, Kiss K.

Head Neck Pathol. 2016 Sep;10(3):362-6. doi: 10.1007/s12105-015-0672-7. Epub 2015 Nov 19.

25.

Psychological and autonomic effects of art making in college-aged students.

Sandmire DA, Rankin NE, Gorham SR, Eggleston DT, French CA, Lodge EE, Kuns GC, Grimm DR.

Anxiety Stress Coping. 2016 Sep;29(5):561-9. doi: 10.1080/10615806.2015.1076798. Epub 2015 Aug 28.

PMID:
26222010
26.

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains.

Alekseyenko AA, Walsh EM, Wang X, Grayson AR, Hsi PT, Kharchenko PV, Kuroda MI, French CA.

Genes Dev. 2015 Jul 15;29(14):1507-23. doi: 10.1101/gad.267583.115.

27.

The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice.

Spaeth JM, Hunter CS, Bonatakis L, Guo M, French CA, Slack I, Hara M, Fisher SE, Ferrer J, Morrisey EE, Stanger BZ, Stein R.

Diabetologia. 2015 Aug;58(8):1836-44. doi: 10.1007/s00125-015-3635-3. Epub 2015 May 29.

28.

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.

Sholl LM, Nishino M, Pokharel S, Mino-Kenudson M, French CA, Janne PA, Lathan C.

J Thorac Oncol. 2015 Jun;10(6):951-9. doi: 10.1097/JTO.0000000000000545.

29.

Foxp1/2/4 regulate endochondral ossification as a suppresser complex.

Zhao H, Zhou W, Yao Z, Wan Y, Cao J, Zhang L, Zhao J, Li H, Zhou R, Li B, Wei G, Zhang Z, French CA, Dekker JD, Yang Y, Fisher SE, Tucker HO, Guo X.

Dev Biol. 2015 Feb 15;398(2):242-54. doi: 10.1016/j.ydbio.2014.12.007. Epub 2014 Dec 17.

30.

Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance.

Schreiweis C, Bornschein U, Burguière E, Kerimoglu C, Schreiter S, Dannemann M, Goyal S, Rea E, French CA, Puliyadi R, Groszer M, Fisher SE, Mundry R, Winter C, Hevers W, Pääbo S, Enard W, Graybiel AM.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14253-8. doi: 10.1073/pnas.1414542111. Epub 2014 Sep 15.

31.

What can mice tell us about Foxp2 function?

French CA, Fisher SE.

Curr Opin Neurobiol. 2014 Oct;28:72-9. doi: 10.1016/j.conb.2014.07.003. Epub 2014 Jul 19. Review.

PMID:
25048596
32.

NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.

French CA, Rahman S, Walsh EM, Kühnle S, Grayson AR, Lemieux ME, Grunfeld N, Rubin BP, Antonescu CR, Zhang S, Venkatramani R, Dal Cin P, Howley PM.

Cancer Discov. 2014 Aug;4(8):928-41. doi: 10.1158/2159-8290.CD-14-0014. Epub 2014 May 29.

33.

Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.

Wang R, Liu W, Helfer CM, Bradner JE, Hornick JL, Janicki SM, French CA, You J.

Cancer Res. 2014 Jun 15;74(12):3332-43. doi: 10.1158/0008-5472.CAN-13-2658. Epub 2014 Apr 15.

34.

Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma.

Puliyel MM, Mascarenhas L, Zhou S, Sapra A, Dal Cin P, French CA, Venkatramani R.

J Clin Oncol. 2014 May 20;32(15):e57-60. doi: 10.1200/JCO.2012.48.5300. Epub 2014 Jan 27. No abstract available.

35.

NUT midline carcinoma: an aggressive intrathoracic neoplasm.

Parikh SA, French CA, Costello BA, Marks RS, Dronca RS, Nerby CL, Roden AC, Peddareddigari VG, Hilton J, Shapiro GI, Molina JR.

J Thorac Oncol. 2013 Oct;8(10):1335-8. doi: 10.1097/JTO.0b013e3182a00f41.

36.

A case of NUT midline carcinoma with no HPV infection, slight EWSR1 rearrangement and strong expression of EGFR.

Maffini F, French CA, Cameron MJ, Stufano V, Barberis M, Pisa E, Manzotti M, Cattaneo A, De Fiori E, Viale G.

Tumori. 2013 Jul-Aug;99(4):e152-5. doi: 10.1700/1361.15114.

PMID:
24326851
37.

MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.

Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM, Aserlind AB, Wang H, Evan G, Kluk MJ, Bradner JE, Aster JC, French CA.

Oncogene. 2014 Mar 27;33(13):1736-1742. doi: 10.1038/onc.2013.126. Epub 2013 Apr 22.

38.

The importance of diagnosing NUT midline carcinoma.

French CA.

Head Neck Pathol. 2013 Mar;7(1):11-6. doi: 10.1007/s12105-013-0428-1. Epub 2013 Mar 5. Review.

39.

Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.

Russell SM, Lechner MG, Mokashi A, Megiel C, Jang JK, Taylor CR, Looijenga LH, French CA, Epstein AL.

Urology. 2013 Feb;81(2):464.e1-9. doi: 10.1016/j.urology.2012.09.029.

40.

[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].

Fang W, French CA, Cameron MJ, Han YD, Liu HG.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):519-24. doi: 10.3760/cma.j.issn.0529-5807.2012.08.003. Chinese.

PMID:
23157742
41.

Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA.

Clin Cancer Res. 2012 Oct 15;18(20):5773-9. doi: 10.1158/1078-0432.CCR-12-1153. Epub 2012 Aug 15.

42.

Ultrastructural features of NUT midline carcinoma.

Wartchow EP, Moore TS, French CA, Mierau GW.

Ultrastruct Pathol. 2012 Aug;36(4):280-4. doi: 10.3109/01913123.2012.664613.

PMID:
22849529
43.

Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM.

Am J Surg Pathol. 2012 Aug;36(8):1222-7. doi: 10.1097/PAS.0b013e318258f03b.

44.

Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.

Fang W, French CA, Cameron MJ, Han Y, Liu H.

Int J Surg Pathol. 2013 Apr;21(2):102-10. doi: 10.1177/1066896912451651. Epub 2012 Jul 9.

PMID:
22777717
45.

NUT rearrangement is uncommon in human thymic epithelial tumors.

Petrini P, French CA, Rajan A, Cameron MJ, Jaffe ES, Zucali PA, Xie J, Wang Y, Giaccone G.

J Thorac Oncol. 2012 Apr;7(4):744-50. doi: 10.1097/JTO.0b013e3182460f8f.

46.

Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.

Lipshultz SE, Landy DC, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AM, Proukou C, Adams MJ, Miller TL.

J Clin Oncol. 2012 Apr 1;30(10):1050-7. doi: 10.1200/JCO.2010.33.7907. Epub 2012 Mar 5.

47.

Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.

Landy DC, Miller TL, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AM, Adams MJ, Lipshultz SE.

Am Heart J. 2012 Feb;163(2):295-301.e2. doi: 10.1016/j.ahj.2011.11.008.

48.

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.

Lee CH, Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, West RB, McAlpine JN, Gilks CB, Yaffe MB, Prentice LM, McPherson A, Jones SJ, Marra MA, Shah SP, van de Rijn M, Huntsman DG, Dal Cin P, Debiec-Rychter M, Nucci MR, Fletcher JA.

Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):929-34. doi: 10.1073/pnas.1115528109. Epub 2012 Jan 5.

49.

A rare case of NUT midline carcinoma.

Ball A, Bromley A, Glaze S, French CA, Ghatage P, Köbel M.

Gynecol Oncol Case Rep. 2012 Oct 8;3:1-3. doi: 10.1016/j.gynor.2012.09.004. eCollection 2012.

50.

Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity.

Davis BN, Karabakhtsian RG, Pettigrew AL, Arnold SM, French CA, Brill YM.

Arch Pathol Lab Med. 2011 Nov;135(11):1494-8. doi: 10.5858/arpa.2010-0389-CR.

PMID:
22032580

Supplemental Content

Loading ...
Support Center